(Q53588126)
Statements
Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. (English)
Laurent Meijer
Ida Iurisci
Elisabeth Filipski
Jens Reinhardt
Stéphane Bach
Athos Gianella-Borradori
Stefano Iacobelli
Francis Lévi
1 November 2006
66
22
10720-10728